Specialty & Oncology February 2020
Oral Targeted Therapies for B-Cell Lymphomas
Over the last two decades, the discovery of novel signaling pathways in B-cell lymphoid malignancies has fueled the development of new drug therapies.
The Role of Direct Oral Anticoagulants in the Management of Heparin-Induced Thrombocytopenia
Direct oral anticoagulants have recently emerged as a potential option for the management of HIT.
Continuing Education
$7.95 Per CE Exam or $69 for 12 Lessons
-
• April 2026 • 2.00 Credits
Managing HIV Coinfections and Complications
-
Pain Management • March 2026 • 2.00 Credits
Updated Guidance for Opioid Use in Pain Management
-
Cardiovascular • February 2026 • 2.00 Credits
Managing Modifiable Risk Factors in Chronic Coronary Disease
Copyright © 2000 - 2024 Jobson Medical Information LLC unless otherwise noted. All rights reserved. Reproduction in whole or in part without permission is prohibited.